Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updates in Diagnosis and Treatment of Acromegaly.
Zahr R, Fleseriu M. Zahr R, et al. Among authors: fleseriu m. Eur Endocrinol. 2018 Sep;14(2):57-61. doi: 10.17925/EE.2018.14.2.57. Epub 2018 Sep 10. Eur Endocrinol. 2018. PMID: 30349595 Free PMC article. Review.
FRAX score in acromegaly: does it tell the whole story?
Brzana J, Yedinak CG, Hameed N, Fleseriu M. Brzana J, et al. Among authors: fleseriu m. Clin Endocrinol (Oxf). 2014 Apr;80(4):614-6. doi: 10.1111/cen.12262. Epub 2013 Jun 27. Clin Endocrinol (Oxf). 2014. PMID: 23745528 No abstract available.
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group. Colao A, et al. Among authors: fleseriu m. J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423324 Free PMC article. Clinical Trial.
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK, Fleck J, Aout M, Pedroncelli AM, Colao A; Pasireotide C2402 Study Group. Gadelha MR, et al. Among authors: fleseriu m. Lancet Diabetes Endocrinol. 2014 Nov;2(11):875-84. doi: 10.1016/S2213-8587(14)70169-X. Epub 2014 Sep 24. Lancet Diabetes Endocrinol. 2014. PMID: 25260838 Clinical Trial.
Pasireotide: a novel treatment for patients with acromegaly.
Cuevas-Ramos D, Fleseriu M. Cuevas-Ramos D, et al. Among authors: fleseriu m. Drug Des Devel Ther. 2016 Jan 11;10:227-39. doi: 10.2147/DDDT.S77999. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26811671 Free PMC article. Review.
228 results